Aligos Therapeutics Inc (ALGS)
0.60
0.00 (0.00%)
USD |
NASDAQ |
May 31, 16:00
0.59
-0.01
(-1.67%)
After-Hours: 20:00
Aligos Therapeutics Profit Margin (Quarterly): -3.54K% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -3.54K% |
| December 31, 2023 | -1.04K% |
| September 30, 2023 | -557.0% |
| June 30, 2023 | -272.9% |
| March 31, 2023 | -843.0% |
| December 31, 2022 | -618.8% |
| September 30, 2022 | -453.5% |
| Date | Value |
|---|---|
| June 30, 2022 | -539.5% |
| March 31, 2022 | -1.39K% |
| December 31, 2021 | -10.28K% |
| September 30, 2021 | -2.16K% |
| June 30, 2021 | -1.93K% |
| March 31, 2021 | -3.04K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-10.28K%
Minimum
Dec 2021
-272.9%
Maximum
Jun 2023
-2.05K%
Average
-1.04K%
Median
Dec 2023
Profit Margin (Quarterly) Benchmarks
| Mirum Pharmaceuticals Inc | -36.52% |
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | -14.54K% |
| IGC Pharma Inc | -2.74K% |
| NovaBay Pharmaceuticals Inc | -122.2% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -137.9% |
| Return on Assets | -83.95% |
| Return on Invested Capital | -137.9% |
| Operating Margin (Quarterly) | -2.24K% |
| Return on Net Operating Assets | -947.4% |